Ventracor has made great progress in the last few months, and we are poised for major expansion as the year develops.
Key milestones achieved include:
* CE Mark approval to market in Europe ? December 2006
* FDA grants conditional approval for Destination Therapy (DT) Clinical Trial protocol ? December 2006
* Feasibility Study ? 10 patient enrolment achieved ? January 2007
* FDA agreement to extension of Feasibility Trial
* FDA agrees to US Bridge to Transplant (BTT) Pivotal Trial protocol, unconditional approval granted ? January 2007
* Australian Government approval of Commercial Ready Grant ? January 2007
A full copy of the document sent to all shareholders is attached. It is also available at
http://www.ventracor.com/uploads/news/VCR_..._March_2007.pdf
- Forums
- ASX - By Stock
- VCR
- investor update ..march 2007
VCR
ventracor limited
investor update ..march 2007
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VCR (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online